2 Results for "

D1-NLS

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "D1-NLS" in MCE Product Catalog:

Cat. No.: HY-122979
CAS No.: 55528-07-9
Synonyms: (+)-AY-23,028; d-Butaclamol hydrochloride
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

(+)-Butaclamol hydrochloride ((+)-AY-23,028; d-Butaclamol hydrochloride) is a dopamine receptor antagonist that blocks D2 and D1 receptors. (+)-Butaclamol hydrochloride antagonizes Dopamine (HY-B0451)-induced relaxation with a KB of 2 nM-0.17 µM and a Ki of 0.19-0.37 µM. (+)-Butaclamol hydrochloride inhibits adenylyl cyclase-coupled dopamine receptors, displaces striatal D2 radioligand binding, and acts as a non-selective D2 antagonist to retain D1-NLS and D1-D2 hetero-oligomers on the cell surface. (+)-Butaclamol hydrochloride inhibits the rewarding effects and self-administration behavior of dopaminergic agonists. (+)-Butaclamol hydrochloride can be used in research related to schizophrenia [1] .
loading...
    loading...
Cat. No.: HY-122979A
CAS No.: 56245-67-1
Synonyms: (+)-AY-23,028 free base; d-Butaclamol
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

(+)-Butaclamol ((+)-AY-23,028 free base; d-Butaclamol) is a dopamine receptor antagonist that blocks D2 and D1 receptors. (+)-Butaclamol antagonizes Dopamine (HY-B0451)-induced relaxation with a KB of 2 nM-0.17 µM and a Ki of 0.19-0.37 µM. (+)-Butaclamol inhibits adenylyl cyclase-coupled dopamine receptors, displaces striatal D2 radioligand binding, and acts as a non-selective D2 antagonist to retain D1-NLS and D1-D2 hetero-oligomers on the cell surface. (+)-Butaclamol inhibits the rewarding effects and self-administration behavior of dopaminergic agonists. (+)-Butaclamol can be used in research related to schizophrenia [1] .
loading...
    loading...